CEP-217

N/A

Report date: 2023/02/04 20:01:20
NME

Base Information

Drug NameCEP-217
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionPhospholipases A2 inhibitors
TargetsPhospholipases A2
Therapy Area/IndicationsBrain IschemiaNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCephalon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCephalon
Active IndicationsN/A
Inactive IndicationsBrain IschemiaNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A